Eurofins Scientific has told investors that divesting from its clinical diagnostics business remains an option as its organic growth in the sector slows.
HBI hears that one of France's top five lab players is in talks to acquire one of the country's biggest regional groups, which we think would make it the biggest group in the country by revenue.
Over half of France's laboratory sites now belong to the market's seven biggest players after rapid M&A activity saw 10% of all sites consolidated in 2018. More deals are on the horizon.
CEE's largest lab company Diagnostyka has partnered with digital symptom checker Infermedica in a bid to capture patient flows and leverage the data it collects.
In the wake of the Falck “dirty tricks” scandal which HBI reported on last week, Danish private companies could soon face the prospect of seeing public contracts cancelled if they are prosecuted.
Russian lab group Citilab, once the second largest player on the market, has apparently seen a drop in revenue over the past three years. HBI investigates.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
